Extracellular matrix molecules in vascular tissue engineering

Surfaces and Interfaces for Biomaterials

Volumn , Issue , 2005, Pages 637-665

  Kielty, C M ^a   Bax, D V ^a   Hodson, N ^a   Sherratt, M J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIALS; BIOTECHNOLOGY;

EXTRACELLULAR MATRIX MOLECULES; VASCULAR TISSUE ENGINEERING;

TISSUE ENGINEERING;

EID: 56349124634     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1533/9781845690809.4.637     Document Type: Chapter

References (115)

1. Buján J., Garcia-Honduvilla N., Bellón J.M. Engineered vascular substitutes: how close are they to the native vessel?. Biotech Applied Biochem 2003, 39:17-27.
2. Quaglino D., Pasquali-Ronchetti I. Morphology and chemical composition of connective tissue: the cardiovascular system. Connective Tissue and its Heritable Disorders 2002, 121-144. Wiley, New York. 2nd edn. P.M. Royce, B. Steinmann (Eds.).
3. Kielty C.M., Grant M.E. The collagen family: structure, assembly and organisation in the extracellular matrix. Connective Tissue and its Heritable Disorders 2002, 159-221. Wiley, New York. 2nd edn. P.M. Royce, B. Steinmann (Eds.).
4. Sinha S., Kielty C.M., Heagerty A.M., Canfield A.E., Shuttleworth C.A. Upregulation of collagen VIII following porcine coronary artery angioplasty is regulated to smooth muscle cell migration not angiogenesis. Int J Exp Path 2001, 82:295-302.
5. Morbidelli L., Donnini S., Chillemi F., Giachetti A., Ziche M. Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin. Clin Cancer Res 2003, 9:5358-5369.
6. Ricard-Blum S., Feraud O., Lortat-Jacob H., Rencurosi A., Fukai N., Dkhissi F., Vittet D., Imberty A., Olsen B.R., Van Der Rest M. Characterization of endostatin binding to heparin and heparan sulfate by surface plasmon resonance and molecular modeling. Role of divalent cations. J Biol Chem 2004, 279:2927-2936.
7. Kielty C.M., Sherratt M.J., Shuttleworth C.A. Elastic fibres. J Cell Sci 2002, 115:2817-2828.
8. Nakamura T., Lozano P.R., Ikeda Y., Iwanaga Y., Hinek A., Minamisawa S., Cheng C.F., Kobuke K., Dalton N., Takada Y., Tashiro K., Ross J., Honjo T., Chien K.R. Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature 2002, 415:171-175.
9. Yanagisawa H., Davis E.C., Starcher B.C., Ouchi T., Yanagisawa M., Richardson J.A., Olson E.N. Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo. Nature 2002, 415:168-171.
10. Sinha S., Heagerty A.M., Shuttleworth C.A., Kielty C.M. Expression of latent TGF-beta binding proteins and association with TGF-beta 1 and fibrillin-1 following arterial injury. Cardiovasc Res 2002, 53:971-983.
11. Merrilees M.J., Lemire J.M., Fischer J.W., Kinsella M.G., Braun K.R., Clowes A.W., Wight T.N. Retrovirally mediated overexpression of versican v3 by arterial smooth muscle cells induces tropoelastin synthesis and elastic fiber formation in vitro and in neointima after vascular injury. Circ Res 2002, 90:481-487.
12. Reinboth B., Hanssen E., Cleary E.G., Gibson M.A. Molecular interactions of biglycan and decorin with elastic fiber components: biglycan forms a ternary complex with tropoelastin and microfibril-associated glycoprotein 1. J Biol Chem 2002, 277:3950-3957.
13. Danielson K.G., Baribault H., Holmes D.F., Graham H., Kadler K.E., Iozzo R.V. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 1997, 136:729-743.
14. Wiberg C., Heinegard D., Wenglen C., Timpl R., Morgelin M. Biglycan organizes collagen VI into hexagonal-like networks resembling tissue structures. J Biol Chem 2002, 277:49120-49126.
15. Owens G.K. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 1995, 75:487-517.
16. Hungerford J.E., Little C.D. Developmental biology of the vascular smooth muscle cell: building a multilayered vessel wall. J Vasc Res 1999, 36:2-27.
17. Shi Y., O'brian J.E., Fard A., Mannion J.D., Zalewski A. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 1996, 94:1655-1664.
18. Gao P.J., Li Y., Sun A.J., Liu J.J., Ji K.D., Zhang Y.Z., Sun W.L., Marche P., Zhu D.L. Differentiation of vascular myofibroblasts induced by transforming growth factor-betal requires the involvement of protein kinase Calpha. J Mol Cell Cardiol 2003, 35:1105-1112.
19. Minguell J.J., Erices A., Conget P. Mesenchymal stem cells. Exp Biol Med 2001, 226:507-520.
20. Ball S.G., Shuttleworth C.A., Kielty C.M. Role of direct cell contact in mesenchymal stem cell fate. Int J Biochem Cell Biol 2004, 36:714-727.
21. Kashiwakura Y., Katoh Y., Tamayose K., Konishi H., Takaya N., Yuhara S., Yamada M., Sugimoto K., Daida H. Isolation of bone marrow stromal cell-derived smooth muscle cells by a human SM22α promoter. Circulation 2003, 107:2078-2081.
22. Kinner J.M., Zaleskas M., Spector M. Regulation of smooth muscle actin expression and contraction in adult human mesenchymal stem cells. Exp Cell Res 2002, 278:72-83.
23. Barry F.P., Murphy J.M. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 2004, 36:568-584.
24. Humphries M.J., Mcewan P.A., Barton S.J., Buckley P.A., Bella J., Mould A.P. Integrin structure: heady advances in ligand binding, but activation still makes the knees wobble. Trends Biochem Sci 2003, 28:313-320.
25. Kielty C.M., Baldock C., Rock M.J., Ashworth J.L., Shuttleworth C.A. Fibrillin: from microfibril assembly to biomechanical function. Phil Trans R Soc Lond B 2002, 357:207-217.
26. Pfaff M., Reinhardt D.P., Sakai L.Y., Timpl R. Cell adhesion and integrin binding to recombinant human fibrillin-1. FEBS Lett 1996, 384:247-250.
27. Sakamoto H., Broekelmann T., Cheresh D.A., Ramirez F., Rosenbloom J., Mecham R.P. Cell-type specific recognition of RGD- and non-RGD-containing cell binding domains in fibrillin-1. J Biol Chem 1996, 271:4916-4922.
28. Bax D.V., Bernard S.E., Lomas A., Morgan A., Humphries J., Shuttleworth C.A., Humphries M.J., Kielty C.M. Cell adhesion to fibrillin-1 molecules and microfibrils is mediated by alpha 5 beta 1 and alpha v beta 3 integrins. J Biol Chem 2003, 278:34605-34616.
29. Mochizuki S., Brassart B., Hinek A. Signaling pathways transduced through the elastin receptor facilitate proliferation of arterial smooth muscle cells. J Biol Chem 2002, 277:44854-44863.
30. Schiemann W.P., Blobe G.C., Kalume D.E., Pandey A., Lodish H.F. Context-specific effects of fibulin-5 (DANCE/EVEC) on cell proliferation, motility, and invasion. Fibulin-5 is induced by transforming growth factor-beta and affects protein kinase cascades. J Biol Chem 2002, 277:27367-27377.
31. Hou G., Mulholland D., Gronska M.A., Bendeck M.P. Type VIII collagen stimulates smooth muscle cell migration and matrix metalloproteinase synthesis after arterial injury. Am J Pathol 2000, 156:467-476.
32. Jain R.K. Molecular regulation of vessel maturation. Nature Med 2003, 9:685-693.
33. Hellstrom M., Kalen M., Lindahl P., Abramsson A., Betsholtz C. Role of PDGF-B and PDGFR-β in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 1999, 126:3047-3055.
34. Sherratt M.J., Holmes D.F., Hasten J.L., Wess T.J., Shuttleworth C.A., Kielty C.M. Fibrillin microfibrils are stiff reinforcing fibres in compliant tissues. J Mol Biol 2003, 332:183-193.
35. Isogai Z., Ono R.N., Ushiro S., Keene D.R., Chen Y., Mazzieri R., Charbonneau N.L., Reinhardt D.P., Rifkin D.B., Sakai L.Y. Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein. J Biol Chem 2003, 278:2750-2757.
36. Kaushal S., Amiel G.E., Guleserian K.J., Shapira O.M., Perry T., Sutherland R.W., Rabkin E., Moran A.M., Schoen F.J., Atala A., Soker S., Bischoff J., Mayer J.E. Functional small-diameter neovessels created using endothelial precursor cells expanded. ex vivo', Nature Med 2001, 7:1035-1040.
37. Walles T., Herden T., Haverich A., Mertsching H. Influence of scaffold thickness and scaffold composition on bioartificial graft survival. Biomaterials 2003, 24:1233-1299.
38. Cukierman E., Pankov R., Stevens D.R., Yamada K.M. Taking cell-matrix interactions to the third dimesion. Science 2001, 294:1708-1712.
39. Cukierman E., Pankov R., Yamada K.M. Cell interactions with three-dimensional matrices. Curr Opin Cell Biol 2002, 14:633-639.
40. Cezeaux J.L., Romoser C.E., Benson R.S., Buck C.K., Sackman J.E. Cell adhesion on polytetrafluoroethylene modified by UV-irradiation in an ammonina atmosphere. Nucl Instrum Meth B 1998, 141:193-196.
41. Vinard E., Leseche G., Andreassian B., Costagliola D. 'In vitro endothelialisation of PTFE vascular grafts: a comparison of various substrates, cell densities, and incubation times. Ann Vasc Surg 1999, 13:141-150.
42. Zhang Z., Wang Z., Liu S., Kodama M. Pore size, tissue ingrowth, and endothelialisation of small diameter microporous polyurethane vascular prostheses. Biomaterials 2003, 25:177-187.
43. Heitz J., Svorcik V., Bacakova L., Rockova K., Ratajova E., Gumpenberger T., Bauerle D., Dvorankova B., Kahr H., Graz I., Romanin C. Cell adhesion on polytetrafluoroethylene modified by UV-irradiation in an ammonia atmosphere. J Biomed Mater Res A 2003, 67A:130-137.
44. Benson R.S. Use of radiation in biomaterials science. Nucl Instrum Meth B 2002, 185:204-209.
45. Yung L.L., Colman R., Cooper S.L. Neutrophil adhesion on polyurethanes preadsorbed with high molecular weight kininogen. Blood 1999, 8:2716-2724.
46. Neff J.A., Tresco P.A., Caldwell K.D. Surface modification for controlled studies of cell-ligand interactions. Biomaterials 1999, 20:2377-2393.
47. Vandervondele A., Voros J., Hubbell J.A. RGD-grafted poly-L-lysine-graft-(polyethylene glycol) copolymers block non-specific protein adsorption while promoting cell adhesion. Biotechnol Bioeng 2003, 82:784-790.
48. Maheshwari G., Brown G., Lauffenburger D.A., Wells A., Griffith L.G. Cell adhesion and motility depend on nanoscale RGD clustering. J Cell Sci 2000, 13:1677-1686.
49. Salacinski H.J., Hamilton G., Seifalian A.M. Surface functionalisation and grafting of heparin and/or RGD in an aqueous-based process to a poly(carbonate-urea)urethane cardiovascular graft for cellular engineering applications. J Biomed Mater Res 2003, 66A:688-697.
50. Tiwari A., Kidane A., Salacinski H.J., Punshon G., Hamilton G., Siefalian A.M. Improving endothelial cell retention for single stage seeding of prosthetic grafts: use of polymer sequences of arginine-glycine-aspartate. Eur J Vasc Endovasc Surg 2003, 25:325-329.
51. Mann B.K., West J.L. Cell adhesion peptides alter smooth muscle cell adhesion, proliferation, migration, and matrix protein synthesis on modified surfaces and in polymer scaffolds. J Biomed Mater Res 1999, 60:86-93.
52. Thomas A.C., Campbell G.R., Campbell J.H. Advances in vascular tissue engineering. Cardiovasc Pathol 2003, 12:271-276.
53. Matsuda H., Miyazaki M., Oka Y., Nakao A., Choda Y., Kokumai Y., Kunitomo K., Tanaka N. A polyurethane vascular access graft and a hybrid polytetrafluoroethylene graft as an arteriovenous fistula for haemodialysis: comparison with an expanded polytetrafluoroethylene graft. Artif Organs 2003, 27:722-727.
54. Sgarbi N., Pisignano D., Di Benedetto F., Gigli G., Cingolani R., Rinaldi R. Self-assembled extracellular matrix protein networks by microcontact printing. Biomaterials 2004, 25:1349-1353.
55. Piner R.D., Zhu J., Xu F., Hong S., Mirkin C.A. "Dip-pen" nanolithography. Science 1999, 283:661-663.
56. Lee K.-B., Lim J.-H., Mirkin C.A. Protein nanostructures formed via direct-write dip-pen lithography. J Am Chem Soc 2003, 125:5588-5589.
57. Zhang M., Bullen D., Chung S.-W., Hong S., Ryu K.S., Fan Z., Mirkin C.A., Liu C. A MEMS nanoplotter with high-density parallel dip-pen nanolithography probe arrays. Nanotechnology 2002, 13:212-217.
58. Haynes C.A., Norde W. Structures and stabilities of adsorbed proteins. J Colloid Interface Sci 1995, 169:313-328.
59. Leckband D. Measuring the forces that control protein interactions. Annu Rev Biophys Biomol Struct 2000, 29:1-26.
60. Muller D.J., Amrein M., Engel A. Adsorption of biological molecules to a solid support for scanning probe microscopy. J Struct Biol 1997, 119:172-188.
61. Bezanilla M., Manne S., Laney D.E., Lyubchenko Y.L., Hansma H.G. Adsorption of DNA to mica, silylated mica and minerals: characterization by atomic force microscopy. Langmuir 1995, 11:655-659.
62. Betley T.A., Banaszak Holl M.M., Orr B.G., Swanson D.R., Tomalia D.A., Baker J.R. Tapping mode atomic force microscopy investigation of poly(amidoamine) dendrimers: effects of substrate and pH on dendrimer deformation. Langmuir 2001, 17:2768-2773.
63. Kowalewski T., Holztman D.M. 'In situ atomic force microscopy study of Alzheimer's β-amyloid. Proc Natl Acad Sci USA 1999, 96:3688-3693.
64. Raghavachari M., Tsai H.-M., Kottke-Marchant K., Marchant R.E. Surface dependent structures of von Willebrand factor observed by AFM under aqueous conditions. Colloids and Surfaces B: Biointerfaces 2000, 19:315-324.
65. Grinnell F., Feld M.K. Adsorption characteristics of plasma fibronectin in relationship to biological activity. J Biomed Mater Res 1981, 15:363-381.
66. Garcia A.J., Vega M.D., Boettiger D. Modulation of cell proliferation and differentiation through substrate-dependent changes in fibronectin conformation. Mol Biol Cell 1999, 10:785-798.
67. Bergkvist M., Carlsson J., Oscarsson S. Surface-dependent conformations of human plasma fibronectin adsorbed to silica, mica, and hydrophobic surfaces, studied with use of atomic force microscopy. J Biomed Mater Res 2003, 64A:349-356.
68. Michael K.E., Verekar V.N., Keselowsky B.G., Meredith J.C., Latour R.A., Garcia A.J. Adsorption-induced conformational changes in fibronectin due to interactions with well-defined surface chemistries. Langmuir 2003, 19:8033-8040.
69. Krammer A., Craig D., Thomas W.E., Schulten K., Vogel V. A structural model for force regulated integrin binding to fibronectin's RGD-synergy site. Matrix Biol 2002, 21:139-147.
70. Sherratt M.J., Holmes D.F., Shuttleworth C.A., Kielty C.M. Scanning transmission electron microscopy mass analysis of fibrillin-containing microfibrils from foetal elastic tissues. Int J Biochem Cell Biol 1997, 29:1063-1070.
71. Bellingham C.M., Woodhouse K.A., Robson P., Rothstein S.J., Keeley F.W. Self-aggregation characteristics of recombinantly expressed human elastin polypeptides. Biochim. Biophys Acta 2001, 1550:6-19.
72. Keeley F.W., Bellingham C.M., Woodhouse K.A. Elastin as a self-organizing biomaterial: use of recombinantly expressed human elastin polypeptides as a model for investigations of structure and self-assembly of elastin. Phil Trans R Soc Lond B 2002, 357:185-189.
73. Miao M., Bellingham C.M., Stahl R., Sitarz E., Lane C., Keeley F.W. Sequence and structure determinants for the self-aggregation of recombinant polypeptides modelled after human elastin. J Biol Chem 2003, 278:48553-48562.
74. Yang G., Woodhouse K.A., Yip C.M. Substrate-facilitated assembly of elastin-like peptides: studies by variable-temperature in situ atomic force microscopy. J Am Chem Soc 2002, 124:10648-10649.
75. Sherratt M.J., Holmes D.F., Shuttleworth C.A., Kielty C.M. Substrate dependent morphology of supra-molecular assemblies: fibrillin and type VI collagen microfibrils. Biophys J 2004, 86:3211-3222.
76. Gobin A.S., West J.L. Val-ala-pro-gly, an elastin-derived non-integrin ligand: smooth muscle cell adhesion and specificity. J Biomed Mater Res 2003, 67A:255-259.
77. Grinnell F. Fibroblast biology in three-dimensional collagen matrices. Trends Cell Biol 2003, 13:264-269.
78. Hubbell J.A. Materials as morphogenetic guides in tissue engineering. Curr Opin Biotechnol 2003, 14:551-558.
79. Elsdale T., Bard J. Collagen substrata for studies of cell behaviour. J Cell Biol 1972, 54:626-637.
80. Sheu M.-T., Huang J.-C., Yeh G.-C., Ho H.-O. Charcterisation of collagen gel solutions and collagen matrices for cell culture. Biomaterials 2001, 22:1713-1719.
81. Charulatha V., Rajaram A. Influence of different crosslinking treatments on the physical properties of collagen membranes. Biomaterials 2003, 24:759-767.
82. Lorand L., Graham R.M. Transglutaminases: crosslinking enzymes with pleiotroic functions. Nature Rev Mol Cell Biol 2003, 4:140-156.
83. Elbjeirami W.M., Yonter E.O., Starcher B.C., West J.L. Enhancing mechanical properties of tissue-engineered constructs via lysyl oxidase crosslinking activity. J Biomed Materials Res 2003, 66A:512-521.
84. Besseau L., Coulomb B., Lebrton-Decoster C., Giraud-Guille M.-M. Production of ordered collagen matrices for three-dimensional cell culture. Biomaterials 2002, 23:27-36.
85. Matthews J.A., Wnek G.E., Simpson D.G., Bowlin G.L. Electrospinning of collagen nanofibers. Biomacromolecules 2002, 3:232-238.
86. Feng Z., Yamato M., Akutsu T., Nakamura T., Okana T., Umena M. Investigation on the mechanical properties of contracted collagen gels as a scaffold for tissue engineering. Artificial Organs 2003, 27:84-91.
87. Baguneid M., Murray D.M., Salacinski H.J., Fuller B., Hamilton B., Walker M.G., Seifalian A.M. Shear stress preconditioning and tissue engineering based paradigms for generating arterial substitutes. Biotechnol Appl Biochem 2003, 39:151-157.
88. Freyman T.M., Yannas I.V., Yokoo R., Gibson L.J. Fibroblast contraction of a collagen-GAG matrix. Biomaterials 2001, 22:2883-2891.
89. Daamen W.F., Van Moerkerk H.T.B., Hafmans T., Buttafoco L., Poot A.A., Veerkamp J.H., Kuppevelt T.H. Preparation and evaluation of molecularly-defined collagen-elastin-glycosaminoglycan scaffolds for tissue engineering. Biomaterials 2003, 24:4001-4009.
90. Berglund J.D., Mohseni M.M., Nerem R.M., Sambanis A. A biological hybrid model for collagen-based tissue engineered vascular constructs. Biomaterials 2003, 24:1241-1254.
91. Bensaïd W., Triffitt J.T., Blanchat C., Oudina K., Sedel L., Petite H. A biodegradable fibrin scaffold for mesenchymal cell transplantation. Biomaterials 2003, 24:2497-2502.
92. Schense J.C., Hubbell J.A. Cross-linking exogenous bifunctinal peptides into fibrin gels with factor XIIIa. Bioconjug Chem 1999, 10:75-81.
93. Grassl E.D., Oegema T.R., Tranquillo R.T. A fibrin-based arterial media equivalent. J Biomed Mater Res 2002, 66A:550-561.
94. Long J.L., Tranquillo R.T. Elastic fiber production in cardiovascular tissue-equivalents. Matrix Biol 2003, 22:339-350.
95. Campoccia D., Doherty P., Radice M., Brun P., Abatangelo G., Williams D.F. Semisynthetic resorbable materials from hyaluronan esterification. Biomaterials 1998, 19:2101-2127.
96. Turner N.J., Kielty C.M., Walker M.G., Canfield A.E. A novel hyaluronan biomaterial (Hyaff-11) as a scaffold for endothelial cells in tissue engineered vascular grafts. Biomaterials 2004, 25:5955-5964.
97. Sherratt M.J., Wess T.J., Baldock C., Ashworth J., Purslow P.P., Shuttleworth C.A., Kielty C.M. Fibrillin-rich microfibrils of the extracellular matrix: ultrastructure and assembly. Micron 2001, 32:185-200.
98. Drury J.L., Mooney D.J. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials 2003, 24:4337-4351.
99. Lutolf M.P., Raeber G.P., Zisch A.H., Halstenberg S., Hubbell J.A. Cell-responsive synthetic hydrogels. Adv Mater 2003, 15:888-892.
100. Lutolf M.P., Hubbell J.A. Synthesis and physicochemical characterization of end-linked poly(ethylene glycol)-co-peptide hydrogels formed by Michael type addition. Biomacromolecules 2003, 4:713-722.
101. Zisch A.H., Lutolf M.P., Ehrbar M., Raeber G.P., Rizzi S.C., Davies N., Schmokel H., Bezuidenhout D., Djonov V., Zilla P., Hubbell J.A. Cell-demanded release of VEGF from synthetic, biointeractive cell-ingrowth matrices for vascularized tissue growth. FASEB J 2003, 17:2260-2262.
102. Sanborn T.J., Messersmith P.B., Barron A.E. In situ crosslinking of a biomimetic peptide-PEG hydrogel via thermally triggered activation of factor XIII. Biomaterials 2002, 23:2703-2710.
103. Nowatzki P.J., Tirrell D.A. Physical properties of artificial extracellular matrix protein films prepared by isocyanate crosslinking. Biomaterials 2004, 25:1261-1267.
104. Shu X.Z., Liu Y., Palumbo F.S., Luo Y., Prestwich G.D. 'In situ crosslinkable hyaluronan hydrogels for tissue engineering. Biomaterials 2003, 24:3825-3834.
105. Park Y.D., Tirelli N., Hubbell J.A. Photopolymerized hyaluronic acid-based hydrogels and interpenetrating networks. Biomaterials 2003, 24:893-900.
106. Yun Y.H., Goetz D.J., Yellen P., Chen W. Hyaluronan microspheres for sustained gene delivery and site-specific targeting. Biomaterials 2004, 25:147-157.
107. Kuo C.K., Ma P.X. Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering: structure, gelation rate and mechanical properties. Biomaterials 2001, 22:511-521.
108. Kong H.J., Smith M.K., Mooney D.J. Designing alginate hydrogels to maintain viability of immobilised cells. Biomaterials 2003, 24:4023-4029.
109. Zisch A.H., Lutolf M.P., Hubbell J.A. Biopolymeric delivery matrices for angiogenic growth factors. Cardiovasc Pathol 2003, 12:295-310.
110. Goerges A.L., Nugent M.A. pH regulates endothelial growth factor binding to fibronectin: a mechanism for the control of extracellular matrix storage and release. J Biol Chem 2004, 279:2307-2315.
111. Tokumaru S., Higashiyama S., Endo T., Nakagawa T., Miyagawa J., Yamamori K., Hanakawa Y., Ohmoto H., Yoshino K., Shirakata Y., et al. Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing. J Cell Biol 2000, 151:209-219.
112. Chinen N., Tanihara M., Nakagawa M., Shinozaki K., Yamamoto E., Mizushima Y., Suzuki Y. Action of microparticles of heparin and alginate crosslinked gel when used as injectable artificial matrices to stabilise basic fibroblast growth factor and induce angiogenesis by controlling its release. J Biomed Mater Res 2003, 67A:61-68.
113. Lu J., Yaszemski M.J., Mikos A.G. TGF-beta1 release from biodegradable polymer microparticles and its effects on marrow stromal osteoblast function. J Bone Join Surg Am 2001, 83A:S82-S91.
114. Elisseeff J., Mcintosh W., Fu W., Blunk B.T., Langer R. Controlled release of IGF-1 and TGF-beta1 in a photopolymerizing hydrogel for cartilage tissue engineering. J Orthop Res 2001, 19:1098-1104.
115. Giannoni P., Hunziker E.B. Release kinetics of transforming growth factor-beta1 from fibroin clots. Biotechnol Bioeng 2003, 83:121-123.